Palisade BIO, Inc.

Biotechnology • Healthcare • Carlsbad, CA, United States • PALI (NCM)

Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases. The company's lead therapeutic candidate is PALI-2108, a prodrug PDE4 inhibitor that is in phase 1a/b clinical trial for the treatment of ulcerative colitis, as well as under phase 1a clinical trial for the treatment of fibrostenotic crohn's disease. It has a research collaboration and license agreement with Giiant Pharma, Inc. for the development, manufacture, and commercialization of its compounds; a license agreement with the Regents of the University of California for sole purpose of maintaining the Newsoara Co-Development; and a co-development and distribution agreement with Newsoara Biopharma Co., Ltd. The company is headquartered in Carlsbad, California.

Stock Performance (90 Days)

Data through Dec 23, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Palisade Bio Announces Strategic Investment from Crohn's & Colitis Foundation to Support Development of PALI-2108 for Ulcerative Colitis and Crohn's Disease - Quiver Quantitative

Quiver Quantitative • Jan 7

Crohn’s & Colitis Foundation backs new gut-targeted drug for severe IBD - Stock Titan

Stock Titan • Jan 7

Palisade Bio (PALI) soars 5% ahead of clinical trial results - MSN

MSN • Jan 6

Palisade Bio Stock Surge: What’s Behind the Rise? - StocksToTrade

StocksToTrade • Dec 10

Palisade Bio Announces Pricing of Upsized $120 Million Underwritten Public Offering of Common Stock - GlobeNewswire

GlobeNewswire • Oct 1

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has PALISADE BIO, INC. had layoffs?

No layoff events have been recorded for PALISADE BIO, INC. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does PALISADE BIO, INC. have?

PALISADE BIO, INC. has approximately 8 employees.

What industry is PALISADE BIO, INC. in?

PALISADE BIO, INC. operates in the Biotechnology industry, within the Healthcare sector.

Is PALISADE BIO, INC. a publicly traded company?

Yes, PALISADE BIO, INC. is publicly traded under the ticker symbol PALI on the NCM. The company has a market capitalization of approximately $0.31 billion.

Where is PALISADE BIO, INC. headquartered?

PALISADE BIO, INC. is headquartered in Carlsbad, CA, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.